Keywords: BioAlliance, Loramyc, marketing approval, Switzerland

BioAlliance Pharma gets Swiss MA for Loramyc

Article | 25 August 2009

Print This

BioAlliance Pharma SA, a French company dedicated to the treatment and supportive care of cancer and AIDS patients, says that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in